This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Verge Analytics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Mark D. Rosen: Innovator in Neurological Treatments
Introduction
Mark D. Rosen is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. His innovative work focuses on developing compounds that can inhibit specific kinases, which are crucial in various medical treatments.
Latest Patents
Mark D. Rosen holds 1 patent for his invention titled "Substituted pyrazolo-pyrimidines and uses thereof." This patent provides compounds that act as inhibitors of PIKfyve kinases, which are useful for treating neurological diseases that can be addressed through the inhibition of PIKfyve. The patent also includes pharmaceutical compositions containing these compounds and outlines methods of treatment utilizing them.
Career Highlights
Mark D. Rosen is currently associated with Verge Analytics, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from neurological conditions.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues, including Robert A. Galemmo, Jr. and Weiling Liang. These partnerships have enhanced the scope and impact of his research.
Conclusion
Mark D. Rosen's contributions to the field of neurological treatments through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile